References
- Axelrod J. Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-meth-amphetamine. Journal of Pharmacology and Experimental Therapeutics 1954; 110: 315–326
- Beckett A. H. Metabolic oxidation of aliphatic basic nitrogen atoms and their α-carbon atoms. Biological Oxidation of Nitrogen in Organic Molecules, J. W. Bridges, J. W. Gorrod, D. V. Parke. Taylor & Francis, London 1972; 53–72
- Beckett A. H., Brookes L. G. The absorption and urinary excretion in man of fenfluramine and its main metabolite. Journal of Pharmacy and Pharmacology 1967; 19(Suppl)42S–49S
- Brownsill R., Wallace D., Taylor A., Campbell B. Study of human urinary metabolism of fenfluramine using gas chromatography-mass spectrometry. Journal of Chromatography; Biomedical Applications 1991; 562: 267–277
- Bruce R. B., Maynard W. R., Jr. Fenfluramine metabolism. Journal of Pharmaceutical Sciences 1968; 57(7)1173–1176
- Caccia S., Ballabio M., Guiso G., Rocchetti M., Garattini S. Species differences in the kinetics and metabolism of fenfluramine isomers. Archives Internationales de Pharmacodynamie et de Therapie 1982; 258: 15–28
- Caccia S., Dagnino G., Garattini S., Guiso G., Madonna R., Zanini M. G. Kinetics of fenfluramine isomers in the rat. European Journal of Drug Metabolism and Pharmacokinetics 1981; 6(4)297–301
- Caldwell J. The metabolism of amphetamines in mammals. Drug Metabolism Reviews 1976; 5(2)219–280
- Dring L. G., Smith R. L., Williams R. T. The metabolic fate of amphetamine in man and other species. Biochemical Journal 1970; 116: 425
- Fleisher M. R., Campbell D. B. Fenfluramine overdosage. Lancet 1969; ii: 1306–1307
- Fuller R. W., Snoddy H. D., Perry K. W. Metabolism of fenfluramine to norfenfluramine in guinea-pigs. Journal of Pharmacy and Pharmacology 1988; 40: 439–441
- Garattini S. Effects of d-fenfluramine on eating disorders. Disorders of Eating Behaviour: A Psychoneuroendocrine Approach, E. Ferrari, F. Brambilla. Pergamon Press, Oxford 1986; 327–341
- Garattini S., Caccia S., Mennini T., Samanin R., Consolo S., Ladinsky H. Biochemical pharmacology of the anorectic drug fenfluramine: a review. Current Medical Research and Opinion 1979; 6(1)15–27
- Garattini S., Mennini T., Samanin R. Reduction of food intake by manipulation of central serotonin, current experimental results. British Journal of Psychiatry 1989; 155(58)41–51
- Hawkins D. R., Midgley O. The synthesis of [14C]-fenfluramine and [14C]-780SE. Journal of Labelled Compounds 1974; 10: 663–670
- Hirsch J. A., Wurtman R. J. Effects of d- or l-isomers of fenfluramine and norfenfluramine on food choice by rats. Mechanism of Action and Tolerance, S. Garattini, R. Samanin. Anoretic Agents: Raven Press, New York 1981; 159
- Midha K., Howes E. M., Cooper J. K. The identification of two new urinary metabolites of fenfluramine in man. Xenobiotica 1983; 13(1)31–38
- Parli C. J., Wang N., McMahon R. E. The mechanism of the oxidation of d-amphetamine by rabbit liver oxygenase. Oxygen-18 studies. Biochemical Biophysics Research Communication 1971; 43(5)1204–1209
- Richards R. P. The metabolism and kinetics of fenfluramine, its optical isomers and a structural analogue, benfluorex. University of Surrey. 1985, PhD Thesis
- Walkenstein S. S., Chumakov N., Seifter J. Detoxication and excretion of mephentermine. Journal of Pharmacology and Experimental Therapeutics 1955; 115: 16–20